Literature DB >> 15986317

Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease.

Sofia A Oliveira1, Yi-Ju Li, Maher A Noureddine, Stephan Zuchner, Xuejun Qin, Margaret A Pericak-Vance, Jeffery M Vance.   

Abstract

We previously reported a linkage region on chromosome 1p (LOD = 3.41) for genes controlling age at onset (AAO) in Parkinson disease (PD). This region overlaps with the previously reported PARK10 locus. To identify the gene(s) associated with AAO and risk of PD in this region, we first applied a genomic convergence approach that combined gene expression and linkage data. No significant results were found. Second, we performed association mapping across a 19.2-Mb region centered under the AAO linkage peak. An iterative association mapping approach was done by initially genotyping single-nucleotide polymorphisms at an average distance of 100 kb apart and then by increasing the density of markers as needed. Using the overall data set of 267 multiplex families, we identified six associated genes in the region, but further screening of a subset of 83 families linked to the chromosome 1 locus identified only two genes significantly associated with AAO in PD: the gamma subunit of the translation initiation factor EIF2B gene (EIF2B3), which was more significant in the linked subset and the ubiquitin-specific protease 24 gene (USP24). Unexpectedly, the human immunodeficiency virus enhancer-binding protein 3 gene (HIVEP3) was found to be associated with risk for susceptibility to PD. We used several criteria to define significant results in the presence of multiple testing, including criteria derived from a novel cluster approach. The known or putative functions of these genes fit well with the current suspected pathogenic mechanisms of PD and thus show great potential as candidates for the PARK10 locus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986317      PMCID: PMC1224528          DOI: 10.1086/432588

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics.

Authors:  Steve Horvath; Xin Xu; Stephen L Lake; Edwin K Silverman; Scott T Weiss; Nan M Laird
Journal:  Genet Epidemiol       Date:  2004-01       Impact factor: 2.135

2.  A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study.

Authors:  S Karamohamed; A L DeStefano; J B Wilk; C M Shoemaker; L I Golbe; M H Mark; A M Lazzarini; O Suchowersky; N Labelle; M Guttman; L J Currie; G F Wooten; M Stacy; M Saint-Hilaire; R G Feldman; K M Sullivan; G Xu; R Watts; J Growdon; M Lew; C Waters; P Vieregge; P P Pramstaller; C Klein; B A Racette; J S Perlmutter; A Parsian; C Singer; E Montgomery; K Baker; J F Gusella; S J Fink; R H Myers; A Herbert
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

3.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal:  Am J Hum Genet       Date:  2003-12-15       Impact factor: 11.025

4.  Genotype-based association test for general pedigrees: the genotype-PDT.

Authors:  E R Martin; M P Bass; J R Gilbert; M A Pericak-Vance; E R Hauser
Journal:  Genet Epidemiol       Date:  2003-11       Impact factor: 2.135

5.  A susceptibility gene for late-onset idiopathic Parkinson's disease.

Authors:  Andrew A Hicks; Hjörvar Pétursson; Thorlákur Jónsson; Hreinn Stefánsson; Hrefna S Jóhannsdóttir; Jesus Sainz; Michael L Frigge; Augustine Kong; Jeffrey R Gulcher; Kári Stefánsson; Sigurlaug Sveinbjörnsdóttir
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

6.  Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage.

Authors:  Michael A Hauser; Yi-Ju Li; Satoshi Takeuchi; Robert Walters; Maher Noureddine; Melinda Maready; Tiffany Darden; Christine Hulette; Eden Martin; Elizabeth Hauser; Hong Xu; Don Schmechel; Judith E Stenger; Fred Dietrich; Jeffery Vance
Journal:  Hum Mol Genet       Date:  2003-03-15       Impact factor: 6.150

7.  Developmental changes of eukaryotic initiation factor 2B subunits in rat hippocampus.

Authors:  Naoko Inamura; Hiroyuki Nawa; Nobuyuki Takei
Journal:  Neurosci Lett       Date:  2003-07-31       Impact factor: 3.046

8.  Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.

Authors:  Yi-Ju Li; Sofia A Oliveira; Puting Xu; Eden R Martin; Judith E Stenger; Clemens R Scherzer; Michael A Hauser; William K Scott; Gary W Small; Martha A Nance; Ray L Watts; Jean P Hubble; William C Koller; Rajesh Pahwa; Mathew B Stern; Bradley C Hiner; Joseph Jankovic; Christopher G Goetz; Frank Mastaglia; Lefkos T Middleton; Allen D Roses; Ann M Saunders; Donald E Schmechel; Steven R Gullans; Jonathan L Haines; John R Gilbert; Jeffery M Vance; Margaret A Pericak-Vance; Christine Hulette; Kathleen A Welsh-Bohmer
Journal:  Hum Mol Genet       Date:  2003-10-21       Impact factor: 6.150

9.  Hereditary early-onset Parkinson's disease caused by mutations in PINK1.

Authors:  Enza Maria Valente; Patrick M Abou-Sleiman; Viviana Caputo; Miratul M K Muqit; Kirsten Harvey; Suzana Gispert; Zeeshan Ali; Domenico Del Turco; Anna Rita Bentivoglio; Daniel G Healy; Alberto Albanese; Robert Nussbaum; Rafael González-Maldonado; Thomas Deller; Sergio Salvi; Pietro Cortelli; William P Gilks; David S Latchman; Robert J Harvey; Bruno Dallapiccola; Georg Auburger; Nicholas W Wood
Journal:  Science       Date:  2004-04-15       Impact factor: 47.728

10.  The kappa B transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding study.

Authors:  Carl E Allen; Chi-ho Mak; Lai-Chu Wu
Journal:  BMC Immunol       Date:  2002-08-22       Impact factor: 3.615

View more
  28 in total

1.  A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan.

Authors:  Yonghong Li; Charles Rowland; Steven Schrodi; Walter Laird; Kristina Tacey; David Ross; Diane Leong; Joseph Catanese; John Sninsky; Andrew Grupe
Journal:  Am J Hum Genet       Date:  2006-06       Impact factor: 11.025

2.  Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.

Authors:  Silke Schmidt; Michael A Hauser; William K Scott; Eric A Postel; Anita Agarwal; Paul Gallins; Frank Wong; Yu Sarah Chen; Kylee Spencer; Nathalie Schnetz-Boutaud; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2006-03-20       Impact factor: 11.025

Review 3.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

4.  Association mapping of the high-grade myopia MYP3 locus reveals novel candidates UHRF1BP1L, PTPRR, and PPFIA2.

Authors:  Felicia Hawthorne; Sheng Feng; Ravikanth Metlapally; Yi-Ju Li; Khanh-Nhat Tran-Viet; Jeremy A Guggenheim; Francois Malecaze; Patrick Calvas; Thomas Rosenberg; David A Mackey; Cristina Venturini; Pirro G Hysi; Christopher J Hammond; Terri L Young
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-21       Impact factor: 4.799

5.  Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic clues.

Authors:  William Lin; Un Jung Kang
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

6.  Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.

Authors:  Todd L Edwards; William K Scott; Cherylyn Almonte; Amber Burt; Eric H Powell; Gary W Beecham; Liyong Wang; Stephan Züchner; Ioanna Konidari; Gaofeng Wang; Carlos Singer; Fatta Nahab; Burton Scott; Jeffrey M Stajich; Margaret Pericak-Vance; Jonathan Haines; Jeffery M Vance; Eden R Martin
Journal:  Ann Hum Genet       Date:  2010-01-08       Impact factor: 1.670

7.  hVMAT2: A Target of Individualized Medication for Parkinson's Disease.

Authors:  Nian Xiong; Nuomin Li; Eden Martin; Jinlong Yu; Jie Li; Jing Liu; David Yue-Wei Lee; Ole Isacson; Jeffery Vance; Hong Qing; Tao Wang; Zhicheng Lin
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

8.  Fine-mapping and candidate gene investigation within the PARK10 locus.

Authors:  Kristoffer Haugarvoll; Mathias Toft; Lisa Skipper; Michael G Heckman; Julia E Crook; Alexandra Soto; Owen A Ross; Mary M Hulihan; Jennifer M Kachergus; Sigrid B Sando; Linda R White; Timothy Lynch; J Mark Gibson; Ryan J Uitti; Zbigniew K Wszolek; Jan O Aasly; Matthew J Farrer
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

9.  Genome-wide loss-of-function analysis of deubiquitylating enzymes for zebrafish development.

Authors:  William K F Tse; Birgit Eisenhaber; Steven H K Ho; Qimei Ng; Frank Eisenhaber; Yun-Jin Jiang
Journal:  BMC Genomics       Date:  2009-12-30       Impact factor: 3.969

10.  Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging.

Authors:  Heather E Wheeler; E Jeffrey Metter; Toshiko Tanaka; Devin Absher; John Higgins; Jacob M Zahn; Julie Wilhelmy; Ronald W Davis; Andrew Singleton; Richard M Myers; Luigi Ferrucci; Stuart K Kim
Journal:  PLoS Genet       Date:  2009-10-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.